Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pacific Biosciences of California, Inc. (PACB)
USD1.52
+0.02 (+1.33%)
US NASDAQ Healthcare Medical - Devices
Address
1305 O’Brien Drive 94025
Menlo Park, CA, US
Menlo Park, CA, US
CEO
Christian O. Henry
Website
pacb.com
IPO
2010-10-27
CIK 1299130 ISIN US69404D1081
Description
Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells. Furthermore, the company supplies a comprehensive suite of workflow-specific reagent kits. These include template preparation kits, which utilize molecular biology reagents (like ligase, buffers, and exonucleases) to convert DNA into SMRTbell double-stranded DNA libraries. Binding kits, featuring modified DNA polymerase, facilitate the crucial attachment of SMRTbell libraries to the polymerase in readiness for sequencing. Finally, specialized sequencing kits contain all necessary reagents, including phospholinked nucleotides, for real-time sequencing directly on their instruments. Pacific Biosciences caters to a broad global clientele, encompassing prominent research institutions, commercial diagnostic laboratories, large-scale genome centers, public health organizations, hospitals, clinical research institutes, contract research organizations (CROs), academic bodies, pharmaceutical firms, and agricultural enterprises. Product commercialization is managed through a direct sales force across North America and Europe, complemented by a robust network of distribution partners spanning Asia, the Middle East, Africa, and Latin America. A significant strategic alliance includes a development and commercialization agreement with Invitae Corporation. Originally incorporated in 2000 as Nanofluidics, Inc., the company adopted its current name, Pacific Biosciences of California, Inc., in 2005. Its corporate headquarters are situated in Menlo Park, California.
News Sentiment (7d)
Based on only 2 articles — low confidence
- Here's Why You Should Add PacBio Stock to Your Portfolio Now Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.52
+0.02 (+1.33%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
2.29
Float Shares
293.97M
Free Float %
97.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.54% | -24.71% | -4.48% | -30.43% | -26.44% | -31.55% | +16.36% | -89.50% | -94.42% | -85.35% | -92.21% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (18 ratings, all time)
Buy
Price Targets & DCF
Current price
1.52
Low
1.00
-34.2%
Consensus
1.00
-34.2%
Median
1.00
-34.2%
High
1.00
-34.2%
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
1.00
-34.2%
|
| Last Quarter | 1 |
1.00
-34.2%
|
| Last Year | 3 |
1.40
-7.9%
|
| All Time | 13 |
5.36
+252.6%
|
Quality scores
Altman Z-Score
-4.49
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+3.9% Q1'26: +0.1% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-70.1% Q1'26: +97.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-24.8% Q1'26: -128.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-336.9% Q1'26: -102.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-111.1% Q1'26: -35.3% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+4.0% Q1'26: +3.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-22.21× Q1'26: -4.64× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
33.86M
est: 44.57M (-24.0%)
|
25.98M
est: 26.32M (-1.3%)
|
28.18M
est: 29.58M (-4.7%)
|
60.59M
est: 65.77M (-7.9%)
|
92.78M
est: 92.97M (-0.2%)
|
90.71M
est: 88.34M (+2.7%)
|
93.47M
est: 90.32M (+3.5%)
|
78.63M
est: 80.21M (-2.0%)
|
90.89M
est: 88.48M (+2.7%)
|
78.89M
est: 76.42M (+3.2%)
|
130.51M
est: 130.49M (+0.0%)
|
128.30M
est: 127.45M (+0.7%)
|
200.52M
est: 200.43M (+0.0%)
|
154.01M
est: 154.98M (-0.6%)
|
160.01M
est: 158.43M (+1.0%)
|
171.24M
167.43M – 172.97M
+8.1% YoY
|
194.86M
194.81M – 194.91M
+13.8% YoY
|
221.79M
220.66M – 222.92M
+13.8% YoY
|
243.33M
237.93M – 245.80M
+9.7% YoY
|
269.93M
263.94M – 272.67M
+10.9% YoY
|
| EBITDA |
-103.29M
est: -120.90M (+14.6%)
|
-87.52M
est: -88.76M (+1.4%)
|
-71.17M
est: -74.95M (+5.0%)
|
-59.11M
est: -61.13M (+3.3%)
|
-25.09M
est: -20.67M (-21.4%)
|
-67.27M
est: -71.72M (+6.2%)
|
-80.83M
est: -79.11M (-2.2%)
|
-92.92M
est: -69.37M (-34.0%)
|
-71.58M
est: -53.12M (-34.7%)
|
38.97M
est: 25.98M (+50.0%)
|
-250.76M
est: -239.99M (-4.5%)
|
-282.24M
est: -255.99M (-10.3%)
|
-271.13M
est: -168.91M (-60.5%)
|
-242.77M
est: -130.61M (-85.9%)
|
-34.20M
est: -133.52M (+74.4%)
|
-144.31M
-145.77M – -141.10M
-8.1% YoY
|
-164.21M
-164.26M – -164.17M
-13.8% YoY
|
-186.91M
-187.87M – -185.96M
-13.8% YoY
|
-205.07M
-207.14M – -200.51M
-9.7% YoY
|
-227.49M
-229.79M – -222.43M
-10.9% YoY
|
| EBIT |
-109.10M
est: -128.20M (+14.9%)
|
-94.19M
est: -95.40M (+1.3%)
|
-76.82M
est: -81.19M (+5.4%)
|
-63.33M
est: -65.09M (+2.7%)
|
-28.77M
est: -25.25M (-14.0%)
|
-71.14M
est: -75.94M (+6.3%)
|
-89.27M
est: -87.84M (-1.6%)
|
-100.14M
est: -75.48M (-32.7%)
|
-81.52M
est: -97.28M (+16.2%)
|
29.67M
est: -130.71M (+122.7%)
|
-262.34M
est: -197.58M (-32.8%)
|
-299.56M
est: -276.11M (-8.5%)
|
-303.82M
est: -200.43M (-51.6%)
|
-296.12M
est: -154.98M (-91.1%)
|
-539.10M
est: -158.43M (-240.3%)
|
-171.24M
-172.97M – -167.43M
-8.1% YoY
|
-194.86M
-194.91M – -194.81M
-13.8% YoY
|
-221.79M
-222.92M – -220.66M
-13.8% YoY
|
-243.33M
-245.80M – -237.93M
-9.7% YoY
|
-269.93M
-272.67M – -263.94M
-10.9% YoY
|
| Net Income |
-109.39M
est: -127.76M (+14.4%)
|
-94.47M
est: -95.52M (+1.1%)
|
-79.29M
est: -83.02M (+4.5%)
|
-66.16M
est: -68.56M (+3.5%)
|
-31.70M
est: -28.41M (-11.6%)
|
-74.38M
est: -79.29M (+6.2%)
|
-92.19M
est: -90.12M (-2.3%)
|
-102.56M
est: -76.84M (-33.5%)
|
-84.13M
est: -66.33M (-26.8%)
|
29.40M
est: 16.75M (+75.5%)
|
-181.22M
est: -177.70M (-2.0%)
|
-314.25M
est: -191.47M (-64.1%)
|
-306.74M
est: -341.10M (+10.1%)
|
-309.85M
est: -468.50M (+33.9%)
|
-546.38M
est: -546.38M (+0.0%)
|
-140.86M
-143.85M – -137.88M
+74.2% YoY
|
-140.21M
-143.19M – -137.24M
+0.5% YoY
|
-119.20M
-135.80M – -102.60M
+15.0% YoY
|
-102.98M
-104.34M – -100.01M
+13.6% YoY
|
-91.99M
-93.20M – -89.33M
+10.7% YoY
|
| SGA |
46.71M
est: 45.56M (+2.5%)
|
47.66M
est: 26.90M (+77.2%)
|
38.75M
est: 30.23M (+28.2%)
|
38.03M
est: 40.20M (-5.4%)
|
45.19M
est: 53.02M (-14.8%)
|
47.79M
est: 50.96M (-6.2%)
|
59.12M
est: 57.97M (+2.0%)
|
63.49M
est: 47.50M (+33.7%)
|
75.49M
est: 76.76M (-1.6%)
|
72.80M
est: 78.11M (-6.8%)
|
124.12M
est: 117.56M (+5.6%)
|
160.85M
est: 130.27M (+23.5%)
|
169.82M
est: 203.33M (-16.5%)
|
175.02M
est: 157.22M (+11.3%)
|
141.49M
est: 160.73M (-12.0%)
|
173.71M
169.85M – 175.47M
+8.1% YoY
|
197.67M
197.62M – 197.72M
+13.8% YoY
|
225.00M
223.85M – 226.15M
+13.8% YoY
|
246.85M
241.37M – 249.35M
+9.7% YoY
|
273.84M
267.75M – 276.61M
+10.9% YoY
|
| EPS |
-2.03
est: -2.81 (+27.8%)
|
-1.69
est: -1.76 (+4.0%)
|
-1.26
est: -1.36 (+7.4%)
|
-0.94
est: -1.02 (+7.8%)
|
-0.42
est: -0.42 (+1.1%)
|
-0.83
est: -0.85 (+2.5%)
|
-0.87
est: -0.90 (+3.0%)
|
-0.76
est: -0.68 (-11.8%)
|
-0.51
est: -0.72 (+28.8%)
|
0.18
est: 0.17 (+3.8%)
|
-0.89
est: -0.85 (-4.2%)
|
-1.40
est: -1.39 (-1.1%)
|
-1.21
est: -1.14 (-6.2%)
|
-1.13
est: -1.35 (+16.5%)
|
-1.82
est: -1.85 (+1.5%)
|
-0.47
-0.48 – -0.46
+74.4% YoY
|
-0.47
-0.48 – -0.46
+0.5% YoY
|
-0.42
-0.45 – -0.34
+11.9% YoY
|
-0.34
-0.35 – -0.33
+17.3% YoY
|
-0.31
-0.31 – -0.30
+10.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-121.00M
OE per share TTM
-0.40
Owner's Yield
-23.98%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
48.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
50
Total invested
17.54M
Insider transactions (90d)
0
Beneficial owners (>5%)
41
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SB Northstar LP | 20.45M | 7.50% | — | 20.45M | — | 20.45M | PN | Cayman Islands | 2024-11-26 | ↗ |
| 2 | Silver Brick Management PTE. LTD. | 20.45M | 7.50% | — | 20.45M | — | 20.45M | CO | Cayman Islands | 2024-11-26 | ↗ |
| 3 | SoftBank Group Corp. | 20.45M | 7.50% | — | 20.45M | — | 20.45M | CO | Cayman Islands | 2024-11-26 | ↗ |
| 4 | EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 20.31M | 7.50% | — | 18.81M | 1.50M | — | FI | France | 2024-11-14 | ↗ |
| 5 | The Vanguard Group - 23-1945930 | 19.85M | 9.00% | — | 256.6K | 19.42M | 437.6K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 6 | ARK Investment Management LLC | 19.84M | 11.23% | 18.99M | 413.9K | 19.84M | — | IA | Delaware, United States | 2020-10-09 | ↗ |
| 7 | Greg Penner | 16.92M | 7.50% | — | 16.92M | — | 16.92M | IN | United States | 2022-06-01 | ↗ |
| 8 | (1) BlackRock, Inc. | 16.57M | 7.50% | 16.08M | — | 16.57M | — | HC | Delaware | 2022-02-03 | ↗ |
| 9 | EDMOND DE ROTHSCHILD ASSET MANAGEMENT (LUXEMBOURG) | 15.00M | 5.50% | — | 15.00M | — | — | FI | Luxembourg | 2024-11-14 | ↗ |
| 10 | EDMOND DE ROTHSCHILD FUND | 14.86M | 5.50% | — | 14.86M | — | — | FI | Luxembourg | 2024-11-14 | ↗ |
| 11 | Jackson Square Partners, LLC | 13.47M | 7.24% | 10.68M | 878.9K | 13.47M | — | IA | Delaware | 2021-02-09 | ↗ |
| 12 | Jameson McJunkin | 13.42M | 6.00% | — | 13.42M | — | 13.42M | IN | United States | 2022-06-01 | ↗ |
| 13 | Madrone Capital Partners, LLC | 13.42M | 6.00% | — | 13.42M | — | 13.42M | OO | Delaware | 2022-06-01 | ↗ |
| 14 | Madrone Opportunity Fund, L.P. | 13.42M | 6.00% | 13.42M | — | 13.42M | — | PN | Delaware | 2022-06-01 | ↗ |
| 15 | Thomas Patterson | 13.42M | 6.00% | — | 13.42M | — | 13.42M | IN | United States | 2022-06-01 | ↗ |
| 16 | Israel A. Englander | 12.40M | 4.50% | — | 12.40M | — | 12.40M | IN | Delaware | 2024-11-08 | ↗ |
| 17 | Millennium Group Management LLC | 12.40M | 4.50% | — | 12.40M | — | 12.40M | OO | Delaware | 2024-11-08 | ↗ |
| 18 | Millennium Management LLC | 12.40M | 4.50% | — | 12.40M | — | 12.40M | OO | Delaware | 2024-11-08 | ↗ |
| 19 | Nikko Asset Management Americas, Inc. | 11.92M | 5.40% | — | 10.92M | — | 11.92M | IA | USA | 2022-02-14 | ↗ |
| 20 | Nikko Asset Management Co., Ltd. (“NAM”) | 11.92M | 5.40% | — | 11.92M | — | — | FI, IA, HC | Japan | 2022-02-04 | ↗ |
| 21 | Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”) | 11.92M | 5.40% | — | 11.92M | — | — | FI, HC | Japan | 2022-02-04 | ↗ |
| 22 | Andrew H. Warford | 11.22M | 9.70% | 11.22M | — | 11.22M | — | HC | Texas | 2018-02-12 | ↗ |
| 23 | Lee S. Ainslie III | 11.22M | 9.70% | 11.22M | — | 11.22M | — | HC | Texas | 2018-02-12 | ↗ |
| 24 | Maverick Capital Management, LLC – 75-2686461 | 11.22M | 9.70% | 11.22M | — | 11.22M | — | HC | Texas | 2018-02-12 | ↗ |
| 25 | Maverick Capital, Ltd. – 75-2482446 | 11.22M | 9.70% | 11.22M | — | 11.22M | — | IA | Texas | 2018-02-12 | ↗ |
| 26 | Capital World Investors ** | 8.13M | 6.90% | 8.13M | — | — | — | IA | Delaware | 2018-02-14 | ↗ |
| 27 | William Ericson | 5.78M | 5.00% | 179.2K | 5.60M | 179.2K | — | IN | United States of America | 2018-02-14 | ↗ |
| 28 | Jonathan Feiber | 5.60M | 4.80% | — | 5.60M | — | — | IN | United States of America | 2018-02-14 | ↗ |
| 29 | Nancy Schoendorf | 5.60M | 4.80% | — | 5.60M | — | — | IN | United States of America | 2018-02-14 | ↗ |
| 30 | Seventh MDV Partners, L.L.C. | 5.60M | 4.80% | — | 5.60M | — | — | OO | Delaware, United States of America | 2018-02-14 | ↗ |
| 31 | MDV VII, L.P. | 5.07M | 4.40% | — | 5.07M | — | — | PN | Delaware, United States of America | 2018-02-14 | ↗ |
| 32 | 98-0557567 | 4.18M | 3.60% | 4.11M | — | 4.18M | — | IA, HC | Bermuda | 2018-02-08 | ↗ |
| 33 | Shimoda Holdings, LLC | 3.50M | 1.60% | — | 3.50M | — | 3.50M | OO | Delaware | 2022-06-01 | ↗ |
| 34 | Consonance Capman GP LLC | 2.46M | 1.65% | — | 2.46M | — | — | HC, OO | Delaware USA | 2019-02-14 | ↗ |
| 35 | Mitchell Blutt | 2.46M | 1.65% | — | 2.46M | — | — | HC, IN | USA | 2019-02-14 | ↗ |
| 36 | Consonance Capital Management LP | 2.39M | 1.64% | — | 2.39M | — | — | IA, PN | Delaware, USA | 2019-02-14 | ↗ |
| 37 | MDV VII Leaders’ Fund, L.P. | 370.3K | 0.30% | — | 370.3K | — | — | PN | Delaware, United States of America | 2018-02-14 | ↗ |
| 38 | MDV ENF VII(A), L.P. | 101.3K | 0.10% | — | 101.3K | — | — | PN | Delaware, United States of America | 2018-02-14 | ↗ |
| 39 | Consonance Capital Opportunity Fund Management LP | 63.0K | 0.04% | — | 63.0K | — | — | IA, PN | Delaware, USA | 2019-02-14 | ↗ |
| 40 | MDV ENF VII(B), L.P. | 52.7K | 0.10% | — | 52.7K | — | — | PN | Delaware, United States of America | 2018-02-14 | ↗ |
| 41 | 95-1411037 | 13.00 | 5.30% | 9.81M | — | 9.81M | — | IA | Delaware | 2021-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
50
-175 vs prev Q
New positions
9
Closed positions
176
Increased
24
Reduced
13
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARK INVESTMENT MANAGEMENT LLC | 37.26M +6.3M (+20.5%) | 69.68M +30.1M (+76.0%) | 12.39% +2.084 pp | 0.46% +0.227 pp | USD10.30 -81.8% | 26 qtrs — |
| 2 | BLACKROCK, INC. | 23.34M +649.2K (+2.9%) | 43.66M +14.6M (+50.3%) | 7.78% +0.222 pp | 0.00% +0.000 pp | USD1.71 +9.4% | 6 qtrs — |
| 3 | SOFTBANK GROUP CORP. | 20.45M +— (+0.0%) | 38.24M +12.1M (+46.1%) | 6.82% +0.005 pp | 0.25% +0.147 pp | USD1.83 +2.2% | 5 qtrs — |
| 4 | VANGUARD GROUP INC | 17.04M +657.3K (+4.0%) | 31.86M +10.9M (+52.0%) | 5.68% +0.223 pp | 0.00% +0.000 pp | USD13.04 -85.7% | 61 qtrs — |
| 5 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 7.81M -869.0K (-10.0%) | 14.60M +3.5M (+31.5%) | 2.60% -0.295 pp | 0.01% +0.002 pp | USD19.53 -90.4% | 22 qtrs — |
| 6 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 7.81M -869.0K (-10.0%) | 14.60M +3.6M (+32.5%) | 2.60% -0.295 pp | 0.17% +0.062 pp | USD19.24 -90.3% | 22 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 7.08M +172.1K (+2.5%) | 13.24M +4.4M (+49.7%) | 2.36% +0.059 pp | 0.00% +0.000 pp | USD9.75 -80.8% | 61 qtrs — |
| 8 | STATE STREET CORP | 5.91M +2.6K (+0.0%) | 11.06M +3.5M (+46.2%) | 1.97% +0.002 pp | 0.00% +0.000 pp | USD6.14 -69.5% | 51 qtrs — |
| 9 | D. E. SHAW & CO., INC. | 4.44M +4.4M (+100.0%) | 8.30M +8.3M (+100.0%) | 1.48% +1.480 pp | 0.00% +0.005 pp | USD1.87 +0.0% | 3 qtrs — |
| 10 | MILLENNIUM MANAGEMENT LLC | 4.34M -572.2K (-11.6%) | 8.12M +1.8M (+29.1%) | 1.45% -0.190 pp | 0.00% +0.001 pp | USD1.40 +33.6% | 52 qtrs — |
| 11 | CASDIN CAPITAL, LLC | 4.22M +3.5M (+483.6%) | 7.90M +7.0M (+752.6%) | 1.41% +1.167 pp | 0.49% +0.413 pp | USD2.98 -37.2% | 10 qtrs — |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 3.85M +3.9M (+100.0%) | 7.20M +7.2M (+100.0%) | 1.28% +1.284 pp | 0.01% +0.011 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 13 | UBS GROUP AG | 3.17M +1.7M (+111.8%) | 5.93M +4.0M (+209.5%) | 1.06% +0.559 pp | 0.00% +0.001 pp | USD1.97 -5.1% | 45 qtrs — |
| 14 | CITADEL ADVISORS LLC | 3.17M +667.9K (+26.7%) | 5.92M +2.7M (+85.1%) | 1.06% +0.223 pp | 0.00% +0.000 pp | USD1.40 +33.6% | 42 qtrs — |
| 15 | POINT72 ASSET MANAGEMENT, L.P. | 2.96M +3.0M (+100.0%) | 5.53M +5.5M (+100.0%) | 0.99% +0.986 pp | 0.01% +0.006 pp | USD1.87 +0.0% | 3 qtrs — |
| 16 | TWO SIGMA INVESTMENTS, LP | 2.88M +2.5M (+616.1%) | 5.38M +4.9M (+946.2%) | 0.96% +0.825 pp | 0.01% +0.007 pp | USD1.79 +4.5% | 20 qtrs — |
| 17 | KOSS-OLINGER CONSULTING, LLC | 2.60M -700.0K (-21.2%) | 4.86M +770.0K (+18.8%) | 0.86% -0.235 pp | 0.38% +0.039 pp | USD1.43 +30.8% | 12 qtrs — |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.47M +38.5K (+1.6%) | 4.61M +1.5M (+48.4%) | 0.82% +0.013 pp | 0.00% +0.000 pp | USD9.38 -80.1% | 59 qtrs — |
| 19 | MORGAN STANLEY | 2.41M +2.0M (+434.2%) | 4.51M +3.9M (+680.5%) | 0.80% +0.653 pp | 0.00% +0.000 pp | USD2.36 -20.8% | 51 qtrs — |
| 20 | NORTHERN TRUST CORP | 2.05M -242.1K (-10.6%) | 3.83M +897.8K (+30.6%) | 0.68% -0.080 pp | 0.00% +0.000 pp | USD8.39 -77.7% | 51 qtrs — |
| 21 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 1.89M +606.2K (+47.0%) | 3.54M +1.9M (+114.8%) | 0.63% +0.201 pp | 0.24% +0.133 pp | USD1.48 +26.4% | 7 qtrs — |
| 22 | BANK OF AMERICA CORP /DE/ | 1.85M +382.1K (+25.9%) | 3.47M +1.6M (+84.0%) | 0.62% +0.128 pp | 0.00% +0.000 pp | USD3.11 -39.9% | 52 qtrs — |
| 23 | AMIRAL GESTION | 2.73M +— (+0.0%) | 3.21M -1.5K (0.0%) | 0.91% -0.002 pp | 1.18% +0.013 pp | USD1.24 +50.8% | 3 qtrs — |
| 24 | PEAK6 LLC | 1.60M +1.0M (+166.7%) | 2.99M +2.2M (+289.6%) | 0.53% +0.332 pp | 0.01% +0.004 pp | USD1.63 +14.7% | 3 qtrs — |
| 25 | JANE STREET GROUP, LLC | 1.50M +1.3M (+533.1%) | 2.81M +2.5M (+824.9%) | 0.50% +0.420 pp | 0.00% +0.000 pp | USD1.78 +5.1% | 26 qtrs — |
| 26 | INVESCO LTD. | 1.43M +326.2K (+29.5%) | 2.68M +1.3M (+89.2%) | 0.48% +0.109 pp | 0.00% +0.000 pp | USD3.13 -40.3% | 24 qtrs — |
| 27 | GOLDMAN SACHS GROUP INC | 1.38M +869.4K (+170.7%) | 2.58M +1.9M (+295.4%) | 0.46% +0.289 pp | 0.00% +0.000 pp | USD3.12 -40.1% | 59 qtrs — |
| 28 | HRT FINANCIAL LP | 1.36M +1.4M (+100.0%) | 2.55M +2.5M (+100.0%) | 0.45% +0.455 pp | 0.01% +0.008 pp | USD1.87 +0.0% | 4 qtrs — |
| 29 | BOURNE LENT ASSET MANAGEMENT INC | 967.1K +— (+0.0%) | 1.81M +570.6K (+46.1%) | 0.32% -0.001 pp | 0.60% +0.160 pp | USD4.03 -53.6% | 44 qtrs — |
| 30 | HHLR ADVISORS, LTD. | 918.9K +— (+0.0%) | 1.72M +542.1K (+46.1%) | 0.31% +0.000 pp | 0.06% +0.027 pp | USD8.35 -77.6% | 10 qtrs — |
| 31 | NUVEEN, LLC | 848.2K +578.0K (+213.9%) | 1.59M +1.2M (+358.6%) | 0.28% +0.193 pp | 0.00% +0.000 pp | USD1.65 +13.3% | 4 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 834.6K +29.0K (+3.6%) | 1.56M +529.5K (+51.4%) | 0.28% +0.009 pp | 0.00% +0.000 pp | USD5.64 -66.8% | 61 qtrs — |
| 33 | TWO SIGMA ADVISERS, LP | 827.5K +827.5K (+100.0%) | 1.55M +1.5M (+100.0%) | 0.28% +0.276 pp | 0.00% +0.003 pp | USD1.87 +0.0% | 20 qtrs — |
| 34 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 808.7K +— (+0.0%) | 1.40M +365.1K (+35.3%) | 0.27% -0.001 pp | 0.00% +0.001 pp | USD1.23 +52.0% | 4 qtrs — |
| 35 | HEADLANDS TECHNOLOGIES LLC | 733.8K +733.8K (+100.0%) | 1.37M +1.4M (+100.0%) | 0.24% +0.245 pp | 0.11% +0.115 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 36 | CAXTON ASSOCIATES LLP | 641.7K +641.7K (+100.0%) | 1.20M +1.2M (+100.0%) | 0.21% +0.214 pp | 0.02% +0.024 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 37 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 634.0K +411.6K (+185.1%) | 1.19M +900.9K (+316.5%) | 0.21% +0.137 pp | 0.00% +0.000 pp | USD2.88 -35.1% | 49 qtrs — |
| 38 | XTX TOPCO LTD | 628.2K +615.9K (+5,001.3%) | 1.17M +1.2M (+7,352.7%) | 0.21% +0.205 pp | 0.03% +0.030 pp | USD1.86 +0.5% | 6 qtrs — |
| 39 | MIRADOR CAPITAL PARTNERS LP | 591.0K +9.6K (+1.7%) | 1.11M +361.0K (+48.5%) | 0.20% +0.003 pp | 0.15% +0.046 pp | USD1.69 +10.7% | 13 qtrs — |
| 40 | VESTMARK ADVISORY SOLUTIONS, INC. | 550.3K -51.2K (-8.5%) | 1.03M +259.2K (+33.7%) | 0.18% -0.018 pp | 0.01% -0.001 pp | USD3.40 -45.0% | 9 qtrs — |
| 41 | CREATIVE PLANNING | 519.7K +200.9K (+63.0%) | 971.9K +563.8K (+138.1%) | 0.17% +0.067 pp | 0.00% +0.000 pp | USD1.54 +21.4% | 7 qtrs — |
| 42 | BIRCHVIEW CAPITAL, LP | 500.0K +— (+0.0%) | 935.0K +295.0K (+46.1%) | 0.17% +0.000 pp | 0.55% +0.064 pp | USD1.25 +49.6% | 3 qtrs — |
| 43 | BARCLAYS PLC | 472.1K -123.0K (-20.7%) | 882.8K -128.9K (-12.7%) | 0.16% -0.041 pp | 0.00% +0.000 pp | USD2.28 -18.0% | 51 qtrs — |
| 44 | CARRET ASSET MANAGEMENT, LLC | 470.0K +50.0K (+11.9%) | 878.9K +341.3K (+63.5%) | 0.16% +0.017 pp | 0.08% +0.031 pp | USD1.32 +41.7% | 15 qtrs — |
| 45 | ARROWMARK COLORADO HOLDINGS LLC | 468.4K +— (+0.0%) | 875.9K +276.3K (+46.1%) | 0.16% +0.000 pp | 0.02% +0.008 pp | USD5.99 -68.8% | 10 qtrs — |
| 46 | GROUP ONE TRADING, L.P. | 460.3K +5.4K (+1.2%) | 860.7K +278.4K (+47.8%) | 0.15% +0.002 pp | 0.00% +0.001 pp | USD1.28 +46.1% | 13 qtrs — |
| 47 | JPMORGAN CHASE & CO | 456.9K -12.0K (-2.6%) | 854.4K +254.3K (+42.4%) | 0.15% -0.004 pp | 0.00% +0.000 pp | USD11.29 -83.4% | 45 qtrs — |
| 48 | SQUAREPOINT OPS LLC | 448.6K -483.5K (-51.9%) | 838.8K -354.3K (-29.7%) | 0.15% -0.161 pp | 0.00% 0.000 pp | USD1.26 +48.4% | 7 qtrs — |
| 49 | ACADIAN ASSET MANAGEMENT LLC | 441.3K +418.1K (+1,808.9%) | 822.0K +793.0K (+2,734.5%) | 0.15% +0.139 pp | 0.00% +0.001 pp | USD1.84 +1.6% | 2 qtrs — |
| 50 | ALLIANCEBERNSTEIN L.P. | 387.1K +— (+0.0%) | 723.8K +228.4K (+46.1%) | 0.13% +0.000 pp | 0.00% +0.000 pp | USD4.98 -62.4% | 61 qtrs — |
| 51 | RHUMBLINE ADVISERS | 361.0K -54.7K (-13.2%) | 675.0K +142.9K (+26.9%) | 0.12% -0.018 pp | 0.00% +0.000 pp | USD8.11 -76.9% | 51 qtrs — |
| 52 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 325.1K -11.0 (0.0%) | 608.0K +191.8K (+46.1%) | 0.11% +0.000 pp | 0.00% +0.000 pp | USD1.20 +55.8% | 7 qtrs — |
| 53 | DIMENSIONAL FUND ADVISORS LP | 323.7K -39.1K (-10.8%) | 603.5K +139.5K (+30.1%) | 0.11% -0.013 pp | 0.00% +0.000 pp | USD9.52 -80.4% | 14 qtrs — |
| 54 | WELLS FARGO & COMPANY/MN | 314.0K +82.1K (+35.4%) | 587.2K +290.3K (+97.8%) | 0.10% +0.027 pp | 0.00% +0.000 pp | USD5.05 -63.0% | 49 qtrs — |
| 55 | GSA CAPITAL PARTNERS LLP | 305.2K -104.2K (-25.5%) | 571.0K +47.0K (+9.0%) | 0.10% -0.035 pp | 0.05% +0.006 pp | USD1.28 +46.1% | 4 qtrs — |
| 56 | LPL FINANCIAL LLC | 274.2K +60.1K (+28.1%) | 512.8K +238.8K (+87.1%) | 0.09% +0.020 pp | 0.00% +0.000 pp | USD8.29 -77.4% | 23 qtrs — |
| 57 | SCIENTECH RESEARCH LLC | 252.9K +252.9K (+100.0%) | 472.9K +472.9K (+100.0%) | 0.08% +0.084 pp | 0.30% +0.297 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 58 | DEUTSCHE BANK AG\ | 219.0K +10.1K (+4.8%) | 409.5K +142.1K (+53.2%) | 0.07% +0.003 pp | 0.00% +0.000 pp | USD8.72 -78.6% | 50 qtrs — |
| 59 | QUADRATURE CAPITAL LTD | 206.4K -145.9K (-41.4%) | 386.0K -63.3K (-14.1%) | 0.07% -0.049 pp | 0.00% -0.001 pp | USD1.28 +46.1% | 2 qtrs — |
| 60 | GRAHAM CAPITAL MANAGEMENT, L.P. | 188.5K +188.5K (+100.0%) | 352.5K +352.5K (+100.0%) | 0.06% +0.063 pp | 0.01% +0.008 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 61 | GREEN ALPHA ADVISORS, LLC | 183.5K +9.4K (+5.4%) | 343.1K +120.3K (+54.0%) | 0.06% +0.003 pp | 0.31% +0.099 pp | USD2.14 -12.6% | 19 qtrs — |
| 62 | RAYMOND JAMES FINANCIAL INC | 183.3K +21.4K (+13.2%) | 342.7K +135.5K (+65.4%) | 0.06% +0.007 pp | 0.00% +0.000 pp | USD1.73 +8.1% | 5 qtrs — |
| 63 | PRICE T ROWE ASSOCIATES INC /MD/ | 163.5K +17.7K (+12.1%) | 306.0K +119.0K (+63.6%) | 0.05% +0.006 pp | 0.00% +0.000 pp | USD10.93 -82.9% | 52 qtrs — |
| 64 | DEKABANK DEUTSCHE GIROZENTRALE | 73.3K +— (+0.0%) | 296.0K +206.0K (+228.9%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD10.06 -81.4% | 22 qtrs — |
| 65 | POLEN CAPITAL MANAGEMENT LLC | 137.1K +137.1K (+100.0%) | 256.5K +256.5K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.001 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 66 | FARALLON CAPITAL MANAGEMENT LLC | 135.0K +— (+0.0%) | 252.5K +79.7K (+46.1%) | 0.05% +0.000 pp | 0.00% +0.001 pp | USD9.99 -81.3% | 13 qtrs — |
| 67 | ADVISORNET FINANCIAL, INC | 133.8K +8.0K (+6.3%) | 250.1K +89.1K (+55.3%) | 0.04% +0.003 pp | 0.01% +0.004 pp | USD2.40 -22.1% | 33 qtrs — |
| 68 | INTECH INVESTMENT MANAGEMENT LLC | 123.9K -8.4K (-6.4%) | 231.8K +62.3K (+36.8%) | 0.04% -0.003 pp | 0.00% +0.001 pp | USD1.56 +19.9% | 6 qtrs — |
| 69 | BENJAMIN EDWARDS INC | 121.9K -12.0K (-8.9%) | 227.9K +56.6K (+33.1%) | 0.04% -0.004 pp | 0.00% +0.001 pp | USD1.79 +4.5% | 17 qtrs — |
| 70 | KOA WEALTH MANAGEMENT, LLC | 120.0K +— (+0.0%) | 224.4K +70.8K (+46.1%) | 0.04% 0.000 pp | 0.15% +0.040 pp | USD9.81 -80.9% | 9 qtrs — |
| 71 | METLIFE INVESTMENT MANAGEMENT, LLC | 116.2K -20.7K (-15.1%) | 217.3K +42.0K (+24.0%) | 0.04% -0.007 pp | 0.00% +0.000 pp | USD4.29 -56.4% | 33 qtrs — |
| 72 | ABACUS WEALTH PARTNERS, LLC | 113.9K +113.9K (+100.0%) | 213.0K +213.0K (+100.0%) | 0.04% +0.038 pp | 0.02% +0.021 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 73 | ENVESTNET ASSET MANAGEMENT INC | 104.6K -36.3K (-25.8%) | 195.6K +15.2K (+8.4%) | 0.03% -0.012 pp | 0.00% +0.000 pp | USD7.73 -75.8% | 17 qtrs — |
| 74 | SG AMERICAS SECURITIES, LLC | 100.8K +30.1K (+42.6%) | 188.0K +98.0K (+108.9%) | 0.03% +0.010 pp | 0.00% 0.000 pp | USD1.46 +28.1% | 29 qtrs — |
| 75 | GABELLI FUNDS LLC | 100.0K +— (+0.0%) | 187.0K +59.0K (+46.1%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD20.46 -90.9% | 17 qtrs — |
| 76 | ABACUS PLANNING GROUP, INC. | 100.0K +— (+0.0%) | 187.0K +59.0K (+46.1%) | 0.03% 0.000 pp | 0.02% +0.007 pp | USD9.87 -81.1% | 22 qtrs — |
| 77 | BANK OF MONTREAL /CAN/ | 99.4K +— (+0.0%) | 185.9K +58.6K (+46.1%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD1.18 +58.5% | 4 qtrs — |
| 78 | AMERICAN CENTURY COMPANIES INC | 94.1K +94.1K (+100.0%) | 175.9K +175.9K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD1.87 +0.0% | 1 qtrs NEW |
| 79 | AQR CAPITAL MANAGEMENT LLC | 87.0K +35.6K (+69.4%) | 162.6K +96.9K (+147.5%) | 0.03% +0.012 pp | 0.00% +0.000 pp | USD1.51 +23.8% | 4 qtrs — |
| 80 | NEW YORK STATE COMMON RETIREMENT FUND | 84.8K +— (+0.0%) | 158.6K +50.0K (+46.1%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD4.37 -57.2% | 43 qtrs — |
| 81 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 82.5K -11.3K (-12.1%) | 154.3K +34.2K (+28.5%) | 0.03% -0.004 pp | 0.00% +0.000 pp | USD8.53 -78.1% | 51 qtrs — |
| 82 | STEEL PEAK WEALTH MANAGEMENT LLC | 81.4K +51.5K (+172.0%) | 152.3K +113.9K (+297.4%) | 0.03% +0.017 pp | 0.01% +0.004 pp | USD1.65 +13.3% | 5 qtrs — |
| 83 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 80.0K -1.2K (-1.5%) | 149.5K +45.6K (+43.9%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD1.67 +12.0% | 5 qtrs — |
| 84 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 71.9K +— (+0.0%) | 134.5K +42.4K (+46.1%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD10.21 -81.7% | 47 qtrs — |
| 85 | STIFEL FINANCIAL CORP | 70.9K +16.2K (+29.5%) | 132.5K +62.5K (+89.2%) | 0.02% +0.005 pp | 0.00% +0.000 pp | USD9.79 -80.9% | 21 qtrs — |
| 86 | BNP PARIBAS ARBITRAGE, SNC | 66.1K +7.7K (+13.3%) | 123.5K +48.9K (+65.5%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD5.18 -63.9% | 51 qtrs — |
| 87 | PROSHARE ADVISORS LLC | 63.8K +5.9K (+10.2%) | 119.3K +45.2K (+60.9%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD7.88 -76.3% | 54 qtrs — |
| 88 | TCG ADVISORY SERVICES, LLC | 61.9K +— (+0.0%) | 115.8K +36.5K (+46.1%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.24 +50.8% | 3 qtrs — |
| 89 | CLEAR HARBOR ASSET MANAGEMENT, LLC | 58.7K -66.6K (-53.1%) | 109.8K -50.6K (-31.5%) | 0.02% -0.022 pp | 0.01% -0.001 pp | USD4.31 -56.6% | 15 qtrs — |
| 90 | IFP ADVISORS, INC | 52.8K -42.8K (-44.8%) | 98.7K -23.7K (-19.3%) | 0.02% -0.014 pp | 0.00% -0.001 pp | USD1.78 +5.1% | 26 qtrs — |
| 91 | HSBC HOLDINGS PLC | 52.7K +52.7K (+100.0%) | 97.8K +97.8K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD1.87 +0.0% | 10 qtrs — |
| 92 | VOYA INVESTMENT MANAGEMENT LLC | 51.5K +— (+0.0%) | 96.4K +30.4K (+46.1%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD9.78 -80.9% | 48 qtrs — |
| 93 | KESTRA PRIVATE WEALTH SERVICES, LLC | 51.2K +1.3K (+2.6%) | 95.7K +31.9K (+49.9%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.27 +47.2% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 72 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ARK Genomic Revolution ETF ARKG | 0.99% | 12.95M | 0.75% |
| 2 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.52% | 114.8K | 0.20% |
| 3 | iShares Genomics Immunology and Healthcare ETF IDNA | 0.49% | 962.8K | 0.47% |
| 4 | Global X - Genomics & Biotechnology ETF GNOM | 0.37% | 324.3K | 0.50% |
| 5 | Global X - Genomics & Biotechnology UCITS ETF GNOM.L | 0.37% | 194.6K | 0.50% |
| 6 | ARK Innovation ETF ARKK | 0.32% | 21.22M | 0.75% |
| 7 | AXS Green Alpha ETF NXTE | 0.30% | 169.9K | 1.00% |
| 8 | WisdomTree BioRevolution UCITS ETF - USD Acc WDNA.L | 0.27% | 60.0K | 0.45% |
| 9 | Horizon Kinetics Medical ETF MEDX | 0.08% | 15.7K | 0.85% |
| 10 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.06% | 1.64M | 0.34% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.00
Bullish
Ratio by volume
1.53
Bullish
Buys
2
Sells
1
Shares acquired
135.3K
Shares disposed
88.2K
Cash buys
—
Cash sales
1.00
Net activity
+47,130
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | Gibson Christopher | Director | A-Award | A | Common Stock | 57,473 | 0.00 | — | 111,386 | D | ↗ |
| 2026-04-01 | Gibson James R II | Officer | S-Sale | D | Common Stock | 88,185 | 1.37 | 120.8K | 1,245,663 | D | ↗ |
| 2026-03-03 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 6,504 | 1.51 | 9.8K | 2,243,634 | D | ↗ |
| 2026-03-03 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 12,497 | 1.51 | 18.9K | 3,581,813 | D | ↗ |
| 2026-03-03 | Gibson Christopher | Director | A-Award | A | Stock Option (right to buy) | 73,087 | 1.52 | 111.1K | 73,087 | D | ↗ |
| 2026-03-03 | Farmer Michele | Officer | S-Sale | D | Common Stock | 2,979 | 1.51 | 4.5K | 305,948 | D | ↗ |
| 2026-02-27 | Van Oene Mark | Officer | A-Award | A | Common Stock | 500,000 | 0.00 | — | 2,242,638 | D | ↗ |
| 2026-02-27 | HENRY CHRISTIAN O | Officer | A-Award | A | Stock Option (right to buy) | 1,841,621 | 1.68 | 3.09M | 1,841,621 | D | ↗ |
| 2026-02-27 | Gibson James R II | Officer | A-Award | A | Stock Option (right to buy) | 667,696 | 1.68 | 1.12M | 667,696 | D | ↗ |
| 2026-02-27 | Farmer Michele | Officer | A-Award | A | Common Stock | 89,835 | 0.00 | — | 308,927 | D | ↗ |
| 2026-02-18 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 55,107 | 1.63 | 89.8K | 1,742,638 | D | ↗ |
| 2026-02-18 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 140,874 | 1.63 | 229.5K | 2,673,500 | D | ↗ |
| 2026-02-18 | Farmer Michele | Officer | S-Sale | D | Common Stock | 14,952 | 1.63 | 24.4K | 219,092 | D | ↗ |
| 2026-02-17 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 129,790 | 1.58 | 204.5K | 1,797,745 | D | ↗ |
| 2026-02-17 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 331,793 | 1.58 | 522.9K | 2,814,374 | D | ↗ |
| 2026-02-17 | Farmer Michele | Officer | S-Sale | D | Common Stock | 35,215 | 1.58 | 55.5K | 234,044 | D | ↗ |
| 2025-08-18 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 26,836 | 1.31 | 35.2K | 1,920,035 | D | ↗ |
| 2025-06-04 | Valantine Hannah | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-06-04 | Smith Christopher M | Director | A-Award | A | Stock Option (right to buy) | 32,500 | 1.03 | 33.5K | 32,500 | D | ↗ |
| 2025-06-04 | Shapiro Lucy | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-06-04 | ORDONEZ KATHY | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-06-04 | MOHR MARSHALL | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-06-04 | MILLIGAN JOHN F | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-06-04 | LIVINGSTON RANDALL S | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-06-04 | Ericson William W. | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 1.03 | 67.0K | 65,000 | D | ↗ |
| 2025-05-19 | Farmer Michele | Officer | S-Sale | D | Common Stock | 5,195 | 1.00 | 5.2K | 269,259 | D | ↗ |
| 2025-03-31 | Gibson James R II | Officer | A-Award | A | Stock Option (right to buy) | 2,000,000 | 1.18 | 2.36M | 2,000,000 | D | ↗ |
| 2025-03-19 | Van Oene Mark | Officer | A-Award | A | Common Stock | 449,176 | 0.00 | — | 1,946,871 | D | ↗ |
| 2025-03-19 | HENRY CHRISTIAN O | Officer | A-Award | A | Common Stock | 920,810 | 0.00 | — | 3,146,167 | D | ↗ |
| 2025-03-19 | Farmer Michele | Officer | A-Award | A | Common Stock | 89,835 | 0.00 | — | 274,454 | D | ↗ |
| 2025-03-03 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 6,486 | 1.41 | 9.1K | 1,497,695 | D | ↗ |
| 2025-03-03 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 12,497 | 1.41 | 17.6K | 2,225,357 | D | ↗ |
| 2025-03-03 | Farmer Michele | Officer | S-Sale | D | Common Stock | 2,973 | 1.41 | 4.2K | 184,619 | D | ↗ |
| 2025-02-18 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 100,773 | 1.88 | 189.3K | 1,496,681 | D | ↗ |
| 2025-02-18 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 259,909 | 1.88 | 488.1K | 2,237,854 | D | ↗ |
| 2025-02-18 | Farmer Michele | Officer | S-Sale | D | Common Stock | 24,349 | 1.88 | 45.7K | 187,592 | D | ↗ |
| 2025-01-30 | Smith Christopher M | Director | A-Award | A | Stock Option (right to buy) | 72,901 | 1.60 | 116.6K | 72,901 | D | ↗ |
| 2025-01-10 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 34,405 | 2.03 | 70.0K | 1,597,454 | D | ↗ |
| 2024-09-30 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 19,782 | 1.72 | 34.1K | 695,654 | D | ↗ |
| 2024-09-16 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 98,907 | 1.75 | 172.7K | 2,497,763 | — | ↗ |
| 2024-08-19 | Eidel Jeff | Officer | S-Sale | D | Common Stock | 26,760 | 1.59 | 42.6K | 869,730 | — | ↗ |
| 2024-08-16 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 38,011 | 1.66 | 63.2K | 1,630,815 | — | ↗ |
| 2024-06-18 | Valantine Hannah | Director | A-Award | A | Common Stock | 22,821 | 0.00 | — | 22,821 | — | ↗ |
| 2024-06-18 | Shapiro Lucy | Director | A-Award | A | Common Stock | 22,821 | 0.00 | — | 22,821 | — | ↗ |
| 2024-06-18 | ORDONEZ KATHY | Director | A-Award | A | Stock Option (right to buy) | 32,179 | 1.65 | 53.1K | 32,179 | — | ↗ |
| 2024-06-18 | Meline David W | Director | A-Award | A | Common Stock | 17,116 | 0.00 | — | 57,116 | — | ↗ |
| 2024-06-18 | MOHR MARSHALL | Director | A-Award | A | Stock Option (right to buy) | 32,179 | 1.65 | 53.1K | 32,179 | — | ↗ |
| 2024-06-18 | MILLIGAN JOHN F | Director | A-Award | A | Common Stock | 22,821 | 0.00 | — | 132,821 | — | ↗ |
| 2024-06-18 | LIVINGSTON RANDALL S | Director | A-Award | A | Stock Option (right to buy) | 32,179 | 1.65 | 53.1K | 32,179 | — | ↗ |
| 2024-06-18 | Ericson William W. | Director | A-Award | A | Common Stock | 22,821 | 0.00 | — | 41,616 | — | ↗ |
| 2024-05-20 | Farmer Michele | Officer | S-Sale | D | Common Stock | 5,275 | 2.03 | 10.7K | 211,941 | — | ↗ |
| 2024-03-15 | ORDONEZ KATHY | Director | M-Exempt | D | Stock Option (right to buy) | 37,106 | 2.63 | 97.6K | 0 | — | ↗ |
| 2024-03-06 | Meline David W | Director | P-Purchase | A | Common Stock | 40,000 | 4.40 | 176.2K | 40,000 | — | ↗ |
| 2024-03-04 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 9,186 | 4.87 | 44.7K | 1,668,826 | — | ↗ |
| 2024-03-04 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 5,275 | 4.87 | 25.7K | 712,260 | — | ↗ |
| 2024-03-04 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 14,177 | 4.87 | 69.1K | 2,596,670 | — | ↗ |
| 2024-03-04 | Farmer Michele | Officer | S-Sale | D | Common Stock | 2,968 | 4.87 | 14.5K | 217,216 | — | ↗ |
| 2024-03-01 | MOHR MARSHALL | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 4.45 | 111.3K | 0 | — | ↗ |
| 2024-02-22 | Van Oene Mark | Officer | A-Award | A | Common Stock | 798,076 | 0.00 | — | 1,674,687 | — | ↗ |
| 2024-02-22 | Kim Susan G. | Officer | A-Award | A | Common Stock | 432,692 | 0.00 | — | 715,450 | — | ↗ |
| 2024-02-22 | HENRY CHRISTIAN O | Officer | A-Award | A | Common Stock | 1,605,769 | 0.00 | — | 2,610,847 | — | ↗ |
| 2024-02-22 | Farmer Michele | Officer | A-Award | A | Common Stock | 115,384 | 0.00 | — | 216,548 | — | ↗ |
| 2024-02-22 | Eidel Jeff | Officer | A-Award | A | Common Stock | 461,538 | 0.00 | — | 893,362 | — | ↗ |
| 2024-02-20 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 831 | 5.26 | 4.4K | 282,758 | — | ↗ |
| 2024-02-20 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 1,979 | 5.26 | 10.4K | 1,005,078 | — | ↗ |
| 2024-02-16 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 33,560 | 5.96 | 200.0K | 876,611 | — | ↗ |
| 2024-02-16 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 22,496 | 5.96 | 134.0K | 283,589 | — | ↗ |
| 2024-02-16 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 79,038 | 5.96 | 470.9K | 1,007,057 | — | ↗ |
| 2024-02-16 | Farmer Michele | Officer | S-Sale | D | Common Stock | 7,562 | 5.96 | 45.1K | 101,164 | — | ↗ |
| 2024-02-16 | Eidel Jeff | Officer | S-Sale | D | Common Stock | 15,498 | 5.96 | 92.3K | 431,824 | — | ↗ |
| 2024-01-09 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 31,012 | 7.77 | 241.1K | 910,171 | — | ↗ |
| 2023-12-14 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 20,000 | 10.00 | 200.0K | 1,086,095 | — | ↗ |
| 2023-10-13 | Meline David W | Director | A-Award | A | Stock Option (right to buy) | 86,954 | 7.98 | 693.9K | 86,954 | — | ↗ |
| 2023-09-29 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 19,257 | 8.44 | 162.5K | 306,085 | — | ↗ |
| 2023-09-18 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 96,844 | 10.12 | 980.3K | 1,106,095 | — | ↗ |
| 2023-09-11 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 10,000 | 10.45 | 104.5K | 1,202,939 | — | ↗ |
| 2023-08-17 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 10,000 | 10.50 | 105.0K | 1,212,939 | — | ↗ |
| 2023-08-17 | Eidel Jeff | Officer | S-Sale | D | Common Stock | 25,936 | 10.60 | 274.8K | 444,666 | — | ↗ |
| 2023-08-16 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 26,102 | 11.00 | 287.1K | 939,769 | — | ↗ |
| 2023-05-24 | Valantine Hannah | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | Shapiro Lucy | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | ORDONEZ KATHY | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | MOHR MARSHALL | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | MILLIGAN JOHN F | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | LIVINGSTON RANDALL S | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | Ericson William W. | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-24 | Botstein David | Director | A-Award | A | Stock Option (right to buy) | 25,775 | 11.94 | 307.8K | 25,775 | — | ↗ |
| 2023-05-18 | MOHR MARSHALL | Director | M-Exempt | A | Common Stock | 25,000 | 2.54 | 63.5K | 85,000 | — | ↗ |
| 2023-05-18 | Farmer Michele | Officer | S-Sale | D | Common Stock | 5,165 | 12.59 | 65.0K | 107,577 | — | ↗ |
| 2023-03-15 | Ericson William W. | Director | M-Exempt | A | Common Stock | 25,000 | 2.54 | 63.5K | 26,336 | — | ↗ |
| 2023-03-03 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 6,268 | 9.49 | 59.5K | 965,871 | — | ↗ |
| 2023-03-03 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 5,045 | 9.49 | 47.9K | 323,505 | — | ↗ |
| 2023-03-03 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 13,769 | 9.49 | 130.7K | 1,222,939 | — | ↗ |
| 2023-03-03 | Farmer Michele | Officer | S-Sale | D | Common Stock | 3,153 | 9.49 | 29.9K | 112,742 | — | ↗ |
| 2023-03-02 | Van Oene Mark | Officer | A-Award | A | Common Stock | 328,500 | 0.00 | — | 972,139 | — | ↗ |
| 2023-03-02 | Kim Susan G. | Officer | A-Award | A | Common Stock | 164,200 | 0.00 | — | 328,550 | — | ↗ |
| 2023-03-02 | HENRY CHRISTIAN O | Officer | A-Award | A | Common Stock | 594,687 | 0.00 | — | 1,236,708 | — | ↗ |
| 2023-03-02 | Farmer Michele | Officer | A-Award | A | Common Stock | 52,100 | 0.00 | — | 115,895 | — | ↗ |
| 2023-03-02 | Eidel Jeff | Officer | A-Award | A | Common Stock | 164,200 | 0.00 | — | 470,602 | — | ↗ |
| 2023-02-17 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 907 | 10.27 | 9.3K | 162,581 | — | ↗ |
| 2023-02-17 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 1,530 | 10.27 | 15.7K | 642,021 | — | ↗ |
| 2023-01-10 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 26,722 | 9.53 | 254.8K | 640,808 | — | ↗ |
| 2022-12-01 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 45,000 | 10.84 | 488.0K | 643,551 | — | ↗ |
| 2022-09-29 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 12,968 | 5.61 | 72.8K | 163,488 | — | ↗ |
| 2022-09-01 | Eidel Jeff | Officer | — | I | Common Stock | 0 | 0.00 | — | 208 | — | ↗ |
| 2022-08-25 | Van Oene Mark | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 667,528 | — | ↗ |
| 2022-08-16 | Eidel Jeff | Officer | A-Award | A | Stock Option (right to buy) | 600,000 | 0.00 | — | 600,000 | — | ↗ |
| 2022-06-10 | MOHR MARSHALL | Director | M-Exempt | A | Common Stock | 35,000 | 1.83 | 64.1K | 60,000 | — | ↗ |
| 2022-05-25 | Valantine Hannah | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 0.00 | — | 63,015 | — | ↗ |
| 2022-05-25 | Shapiro Lucy | Director | A-Award | A | Stock option (right to buy) | 63,015 | 5.37 | 338.4K | 63,015 | — | ↗ |
| 2022-05-25 | ORDONEZ KATHY | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 0.00 | — | 63,015 | — | ↗ |
| 2022-05-25 | MOHR MARSHALL | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 0.00 | — | 63,015 | — | ↗ |
| 2022-05-25 | MILLIGAN JOHN F | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 0.00 | — | 63,015 | — | ↗ |
| 2022-05-25 | LIVINGSTON RANDALL S | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 0.00 | — | 63,015 | — | ↗ |
| 2022-05-25 | Ericson William W. | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 5.37 | 338.4K | 63,015 | — | ↗ |
| 2022-05-25 | Botstein David | Director | A-Award | A | Stock Option (right to buy) | 63,015 | 0.00 | — | 63,015 | — | ↗ |
| 2022-05-18 | Farmer Michele | Officer | S-Sale | D | Common Stock | 3,573 | 5.55 | 19.8K | 60,354 | — | ↗ |
| 2022-03-17 | Ericson William W. | Director | J-Other | D | Common Stock | 4,848,397 | 0.00 | — | 0 | — | ↗ |
| 2022-03-02 | Van Oene Mark | Officer | A-Award | A | Stock Option (right to buy) | 433,200 | 0.00 | — | 433,200 | — | ↗ |
| 2022-03-02 | Kim Susan G. | Officer | A-Award | A | Stock Option (right to buy) | 239,000 | 11.70 | 2.80M | 239,000 | — | ↗ |
| 2022-03-02 | HENRY CHRISTIAN O | Officer | A-Award | A | Stock Option (right to buy) | 642,300 | 0.00 | — | 642,300 | — | ↗ |
| 2022-03-02 | Fromen Peter | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 190,280 | — | ↗ |
| 2022-03-02 | Farmer Michele | Officer | A-Award | A | Stock Option (right to buy) | 44,800 | 0.00 | — | 44,800 | — | ↗ |
| 2022-02-17 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 1,062 | 11.06 | 11.7K | 134,966 | — | ↗ |
| 2022-02-17 | HENRY CHRISTIAN O | Officer | S-Sale | D | Commons Stock | 2,122 | 11.09 | 23.5K | 672,358 | — | ↗ |
| 2022-02-16 | ORDONEZ KATHY | Director | S-Sale | D | Common Stock | 3,280 | 11.50 | 37.7K | 18,595 | — | ↗ |
| 2022-01-14 | MOHR MARSHALL | Director | M-Exempt | A | Common Stock | 25,000 | 3.57 | 89.3K | 25,000 | — | ↗ |
| 2022-01-11 | Van Oene Mark | Officer | S-Sale | D | Common Stock | 41,480 | 14.23 | 590.3K | 293,520 | — | ↗ |
| 2022-01-11 | Fromen Peter | Officer | S-Sale | D | Common Stock | 19,720 | 14.30 | 282.0K | 140,280 | — | ↗ |
| 2021-09-29 | Kim Susan G. | Officer | S-Sale | D | Common Stock | 20,272 | 25.75 | 522.0K | 136,028 | — | ↗ |
| 2021-09-16 | HENRY CHRISTIAN O | Officer | S-Sale | D | Common Stock | 90,520 | 26.91 | 2.44M | 674,480 | — | ↗ |
| 2021-06-16 | Valantine Hannah | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-16 | Shapiro Lucy | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-06-16 | ORDONEZ KATHY | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-06-16 | MOHR MARSHALL | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-06-16 | MILLIGAN JOHN F | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-06-16 | LIVINGSTON RANDALL S | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-06-16 | Ericson William W. | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-06-16 | Botstein David | Director | A-Award | A | Stock Option (right to buy) | 12,885 | 27.90 | 359.5K | 12,885 | — | ↗ |
| 2021-05-25 | Ericson William W. | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 1.83 | 45.8K | 0 | — | ↗ |
| 2021-05-17 | Farmer Michele | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2021-02-26 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 170,824 | 30.69 | 5.24M | 911,827 | — | ↗ |
| 2021-02-25 | Hunkapiller Michael | Director | M-Exempt | A | Common Stock | 67,736 | 5.72 | 387.4K | 916,141 | — | ↗ |
| 2021-02-24 | Hunkapiller Michael | Director | M-Exempt | D | Stock Option (right to buy) | 90,560 | 5.72 | 518.0K | 177,485 | — | ↗ |
| 2021-02-23 | Hunkapiller Michael | Director | M-Exempt | A | Common Stock | 86,022 | 7.87 | 677.0K | 1,106,576 | — | ↗ |
| 2021-02-22 | Schaefer Eric | Officer | S-Sale | D | Common Stock | 3,842 | 39.20 | 150.6K | 88,474 | — | ↗ |
| 2021-02-22 | Hunkapiller Michael | Director | M-Exempt | D | Stock Option (right to buy) | 45,895 | 2.63 | 120.7K | 54,105 | — | ↗ |
| 2021-02-16 | Schaefer Eric | Officer | A-Award | A | Stock Option (right to buy) | 10,100 | 46.37 | 468.3K | 10,100 | — | ↗ |
| 2021-02-16 | ORDONEZ KATHY | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 5.79 | 144.8K | 0 | — | ↗ |
| 2021-02-16 | Kim Susan G. | Officer | A-Award | A | Common Stock | 6,300 | 0.00 | — | 156,300 | — | ↗ |
| 2021-02-16 | HENRY CHRISTIAN O | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 765,000 | — | ↗ |
| 2021-02-12 | Shapiro Lucy | Director | S-Sale | D | Common Stock | 101,666 | 50.40 | 5.12M | 0 | — | ↗ |
| 2021-02-12 | LIVINGSTON RANDALL S | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 2.54 | 63.5K | 0 | — | ↗ |
| 2021-02-12 | Ericson William W. | Director | J-Other | A | Common Stock | 68 | 0.00 | — | 68 | — | ↗ |
| 2021-02-12 | Botstein David | Director | M-Exempt | D | Stock Option (right to buy) | 25,000 | 4.45 | 111.3K | 0 | — | ↗ |
| 2021-01-25 | Hunkapiller Michael | Director | M-Exempt | D | Stock Option (right to buy) | 125,406 | 6.14 | 770.0K | 167,500 | — | ↗ |
| 2021-01-22 | Hunkapiller Michael | Director | M-Exempt | D | Stock Option (right to buy) | 150,857 | 6.14 | 926.3K | 292,906 | — | ↗ |
| 2021-01-21 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 700 | 38.06 | 26.6K | 901,871 | — | ↗ |
| 2021-01-20 | Hunkapiller Michael | Director | M-Exempt | D | Stock Option (right to buy) | 215,026 | 2.27 | 488.1K | 152,474 | — | ↗ |
| 2021-01-08 | Van Oene Mark | Officer | A-Award | A | Stock Option (right to buy) | 750,000 | 36.70 | 27.53M | 750,000 | — | ↗ |
| 2021-01-08 | Fromen Peter | Officer | A-Award | A | Stock Option (right to buy) | 320,000 | 36.70 | 11.74M | 320,000 | — | ↗ |
| 2020-12-22 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 90,459 | 26.34 | 2.38M | 935,770 | — | ↗ |
| 2020-12-21 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 16,698 | 21.55 | 359.8K | 1,203,196 | — | ↗ |
| 2020-11-24 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 1,492 | 14.39 | 21.5K | 0 | — | ↗ |
| 2020-11-23 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 251,837 | 15.03 | 3.79M | 1,492 | — | ↗ |
| 2020-11-20 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 147,799 | 15.11 | 2.23M | 253,329 | — | ↗ |
| 2020-11-19 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 2,201 | 15.55 | 34.2K | 401,128 | — | ↗ |
| 2020-11-18 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 38,381 | 15.71 | 603.0K | 403,329 | — | ↗ |
| 2020-11-16 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 42,488 | 15.90 | 675.3K | 441,710 | — | ↗ |
| 2020-11-12 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 200,000 | 16.73 | 3.35M | 484,198 | — | ↗ |
| 2020-11-11 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 195,652 | 14.25 | 2.79M | 898,215 | — | ↗ |
| 2020-11-10 | Hunkapiller Michael | Director | S-Sale | D | Common Stock | 1,304,348 | 14.25 | 18.59M | 1,093,867 | — | ↗ |
| 2020-10-15 | MILLIGAN JOHN F | Director | A-Award | A | Stock Option (right to buy) | 35,000 | 14.34 | 501.9K | 35,000 | — | ↗ |
| 2020-09-28 | Kim Susan G. | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 9.60 | 3.84M | 400,000 | — | ↗ |
| 2020-09-15 | HENRY CHRISTIAN O | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,500,000 | 7.32 | 10.98M | 1,500,000 | — | ↗ |
| 2020-08-25 | Hunkapiller Michael | Director / Officer | S-Sale | D | Common Stock | 228,632 | 6.44 | 1.47M | 934,198 | — | ↗ |
| 2020-08-24 | MILLIGAN JOHN F | Director | M-Exempt | D | Stock Option (right to buy) | 35,000 | 2.67 | 93.5K | 0 | — | ↗ |
| 2020-08-24 | Hunkapiller Michael | Director / Officer | S-Sale | D | Common Stock | 259,164 | 6.63 | 1.72M | 1,162,830 | — | ↗ |
| 2020-08-21 | Hunkapiller Michael | Director / Officer | S-Sale | D | Common Stock | 189,847 | 6.57 | 1.25M | 1,421,994 | — | ↗ |
| 2020-08-20 | Hunkapiller Michael | Director / Officer | S-Sale | D | Common Stock | 256,554 | 6.47 | 1.66M | 1,611,841 | — | ↗ |
| 2020-08-08 | Gong Benjamin B | Officer | — | D | Stock Option (right to buy) | 50,000 | 7.05 | 352.5K | 0 | — | ↗ |
| 2020-08-04 | Shapiro Lucy | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | ORDONEZ KATHY | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | MOHR MARSHALL | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | MILLIGAN JOHN F | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | LIVINGSTON RANDALL S | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | HENRY CHRISTIAN O | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | Ericson William W. | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-08-04 | Botstein David | Director | A-Award | A | Stock Option (right to buy) | 97,785 | 3.89 | 380.4K | 97,785 | — | ↗ |
| 2020-05-26 | Schaefer Eric | Officer | — | D | Stock Option (right to buy) | 2,250 | 6.91 | 15.5K | 0 | — | ↗ |
| 2020-04-01 | Zaccarin Denis | Officer | — | D | Stock Option (right to buy) | 20,000 | 2.18 | 43.6K | 0 | — | ↗ |
| 2020-04-01 | Seipert Christopher J. | Officer | — | D | Stock Option (right to buy) | 18,000 | 8.90 | 160.2K | 0 | — | ↗ |
| 2020-03-24 | Phillips James Michael | Officer | S-Sale | D | Common Stock | 2,760 | 3.05 | 8.4K | 249,220 | — | ↗ |
| 2020-03-16 | Hunkapiller Michael | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 2,548,215 | — | ↗ |
| 2020-03-16 | HENRY CHRISTIAN O | Director | A-Award | A | Stock Option (right to buy) | 35,000 | 2.45 | 85.8K | 35,000 | — | ↗ |
| 2020-02-20 | Phillips James Michael | Officer | S-Sale | D | Common Stock | 5,050 | 4.48 | 22.6K | 251,980 | — | ↗ |
| 2020-02-20 | Hunkapiller Michael | Director / Officer | S-Sale | D | Common Stock | 166,575 | 4.50 | 749.8K | 1,868,395 | — | ↗ |
| 2020-02-19 | Hunkapiller Michael | Director / Officer | S-Sale | D | Common Stock | 76,281 | 4.49 | 342.3K | 2,034,970 | — | ↗ |
| 2020-02-19 | BARNES SUSAN K | Officer | S-Sale | D | Common Stock | 12,558 | 4.44 | 55.8K | 874,812 | — | ↗ |
| 2020-02-18 | Phillips James Michael | Officer | A-Award | A | Common Stock | 20,000 | 0.00 | — | 257,030 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-9.4K
Shares Outstanding
302.00M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Christian O. Henry President and Chief Executive Officer | 748.3K | — | 1.15M | 1.70M | 714.3K | — | 4.31M | 66.06% | ↗ |
| 2 | 2025 | Jim R. Gibson | 376.9K | — | 1.18M | 1.74M | 198.1K | — | 3.49M | 83.54% | ↗ |
| 3 | 2025 | Mark Van Oene Chief Operating Officer | 620.1K | — | 561.5K | 827.5K | 357.1K | — | 2.37M | 58.70% | ↗ |
| 4 | 2024 | Christian O. Henry President and Chief Executive Officer | 725.0K | — | 8.24M | — | 219.0K | — | 9.18M | 89.72% | ↗ |
| 5 | 2024 | Mark Van Oene Chief Operating Officer | 602.0K | — | 4.09M | — | 108.9K | — | 4.81M | 85.21% | ↗ |
| 6 | 2024 | Jeff Eidel Former Chief Commercial Officer | 420.2K | — | 2.37M | — | — | 545.3K | 3.33M | 71.03% | ↗ |
| 7 | 2024 | Susan G. Kim Former Chief Financial Officer | 449.7K | — | 2.22M | — | — | — | 2.67M | 83.15% | ↗ |
| 8 | 2023 | Christian O. Henry President and Chief Executive Officer | 695.1K | — | 6.64M | — | 700.2K | 15.3K | 8.05M | 82.47% | ↗ |
| 9 | 2023 | Christian O. Henry President, Chief Executive Officer | 695.1K | — | 6.64M | — | 700.2K | 15.3K | 8.05M | 82.47% | ↗ |
| 10 | 2023 | Mark Van Oene Chief Operating Officer | 583.5K | — | 3.67M | — | 352.1K | — | 4.60M | 79.67% | ↗ |
| 11 | 2023 | Jeff Eidel Former Chief Commercial Officer | 456.3K | — | 1.83M | — | 230.0K | 15.3K | 2.53M | 72.31% | ↗ |
| 12 | 2023 | Jeff Eidel Chief Commercial Officer | 456.3K | — | 1.83M | — | 230.0K | 15.3K | 2.53M | 72.31% | ↗ |
| 13 | 2023 | Susan G. Kim Former Chief Financial Officer | 457.2K | — | 1.83M | — | 230.0K | — | 2.52M | 72.72% | ↗ |
| 14 | 2023 | Susan G. Kim Chief Financial Officer | 457.2K | — | 1.83M | — | 230.0K | — | 2.52M | 72.72% | ↗ |
| 15 | 2022 | Christian O. Henry President, Chief Executive Officer | 666.7K | — | 1.26M | 4.26M | 375.2K | 56.4K | 6.62M | 83.40% | ↗ |
| 16 | 2022 | Christian O. Henry President, Chief Executive Officer | 666.7K | — | 1.26M | 4.26M | 375.2K | 56.4K | 6.62M | 83.40% | ↗ |
| 17 | 2022 | Mark Van Oene Chief Operating Officer | 564.2K | — | 2.92M | 2.87M | 190.5K | 17.4K | 6.56M | 88.24% | ↗ |
| 18 | 2022 | Mark Van Oene Chief Operating Officer | 564.2K | — | 2.92M | 2.87M | 190.5K | 17.4K | 6.56M | 88.24% | ↗ |
| 19 | 2022 | Jeff Eidel Chief Commercial Officer | 164.3K | 225.0K | 2.40M | 2.97M | 46.4K | — | 5.80M | 92.49% | ↗ |
| 20 | 2022 | Jeff Eidel Chief Commercial Officer | 164.3K | 225.0K | 2.40M | 2.97M | 46.4K | — | 5.80M | 92.49% | ↗ |
| 21 | 2022 | Peter Fromen Former Chief Commercial Officer | 170.5K | — | 585.0K | 1.98M | — | 169.0K | 2.91M | 88.32% | ↗ |
| 22 | 2022 | Susan G. Kim Chief Financial Officer | 440.8K | — | 468.0K | 1.59M | 124.0K | — | 2.62M | 78.42% | ↗ |
| 23 | 2022 | Susan G. Kim Chief Financial Officer | 440.8K | — | 468.0K | 1.59M | 124.0K | — | 2.62M | 78.42% | ↗ |
| 24 | 2021 | Mark Van Oene Chief Operating Officer | 539.8K | 200.0K | 12.29M | 14.89M | 375.8K | — | 28.30M | 96.06% | ↗ |
| 25 | 2021 | Peter Fromen Former Chief Commercial Officer | 417.1K | 125.0K | 5.87M | 6.35M | 242.0K | 329.0K | 13.34M | 91.65% | ↗ |
| 26 | 2021 | Peter Fromen Chief Commercial Officer | 417.1K | 125.0K | 5.87M | 6.35M | 242.0K | 329.0K | 13.34M | 91.65% | ↗ |
| 27 | 2021 | Christian O. Henry President, Chief Executive Officer | 650.0K | — | 695.6K | 752.5K | 754.7K | 14.2K | 2.87M | 50.51% | ↗ |
| 28 | 2021 | Denis Zaccarin, Ph.D. Senior Vice President, Product Development | 330.5K | — | 466.0K | 504.2K | 180.2K | — | 1.48M | 65.51% | ↗ |
| 29 | 2021 | Susan G. Kim Chief Financial Officer | 421.9K | — | 292.1K | 316.1K | 249.6K | — | 1.28M | 47.53% | ↗ |
| 30 | 2020 | Christian O. Henry President, Chief Executive Officer | 194.6K | 31.7K | 5.49M | 6.35M | 183.3K | 233.3K | 12.48M | 94.85% | ↗ |
| 31 | 2020 | Susan G. Kim Chief Financial Officer | 108.5K | 95.2K | 1.44M | 2.22M | 35.1K | — | 3.90M | 93.87% | ↗ |
| 32 | 2020 | Michael Hunkapiller, Ph.D. Former President, Chief Executive Officer | 582.9K | — | 551.3K | — | — | 582.9K | 1.72M | 32.10% | ↗ |
| 33 | 2020 | Susan K. Barnes Former Executive Vice President Chief Financial Officer | 281.4K | — | 676.5K | — | — | — | 957.9K | 70.63% | ↗ |
| 34 | 2020 | Denis Zaccarin, Ph.D. Senior Vice President, Product Development | 321.6K | 43.4K | 270.6K | — | 75.4K | — | 711.0K | 38.06% | ↗ |
| 35 | 2019 | Michael Hunkapiller, Ph.D. Former President, Chief Executive Officer | 582.9K | — | 276.3K | — | 523.5K | — | 1.38M | 19.98% | ↗ |
| 36 | 2019 | Michael Hunkapiller, Ph.D. President and Chief Executive Officer | 582.9K | — | 276.3K | — | 523.5K | — | 1.38M | 19.98% | ↗ |
| 37 | 2019 | Susan K. Barnes Executive Vice President and Chief Financial Officer | 401.5K | — | 151.5K | — | 234.4K | — | 787.4K | 19.24% | ↗ |
| 38 | 2019 | Susan K. Barnes Former Executive Vice President Chief Financial Officer | 401.5K | — | 151.5K | — | 234.4K | — | 787.4K | 19.24% | ↗ |
| 39 | 2019 | Michael Phillips Former Senior Vice President of Research and Development | 355.4K | — | 112.2K | — | 143.6K | — | 611.2K | 18.36% | ↗ |
| 40 | 2018 | Michael Hunkapiller, Ph.D. Former President, Chief Executive Officer | 1.00 | — | 427.4K | 153.5K | 1.03M | — | 1.61M | 36.06% | ↗ |
| 41 | 2018 | Michael Hunkapiller, Ph.D. President and Chief Executive Officer | 1.00 | — | 427.4K | 153.5K | 1.03M | — | 1.61M | 36.06% | ↗ |
| 42 | 2018 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of | 1.00 | 1.03M | 427.4K | — | — | — | 1.61M | 26.53% | ↗ |
| 43 | 2018 | Susan K. Barnes Former Executive Vice President Chief Financial Officer | 1.00 | — | 374.0K | 134.3K | 617.5K | — | 1.13M | 45.15% | ↗ |
| 44 | 2018 | Susan K. Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | 374.0K | 134.3K | 617.5K | — | 1.13M | 45.15% | ↗ |
| 45 | 2018 | Kathy Ordoñez Chief Commercial Officer and member of the Board of Directors | 1.00 | 170.0K | 374.0K | — | — | — | 678.3K | 55.13% | ↗ |
| 46 | 2018 | Michael Phillips Senior Vice President of Research and Development | 345.0K | 35.4K | 132.8K | — | — | — | 617.0K | 21.53% | ↗ |
| 47 | 2018 | Michael Phillips Former Senior Vice President of Research and Development | 345.0K | — | 132.8K | 103.8K | 35.4K | — | 617.0K | 38.35% | ↗ |
| 48 | 2018 | Kevin Corcoran Senior Vice President of Market Development | 336.8K | — | 139.2K | — | — | — | 594.6K | 23.41% | ↗ |
| 49 | 2017 | Michael Hunkapiller, Ph.D. President and Chief Executive Officer | 1.00 | — | — | 1.34M | — | — | 1.34M | 100.00% | ↗ |
| 50 | 2017 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 1.00 | — | — | — | — | — | 1.34M | 0.00% | ↗ |
| 51 | 2017 | Susan Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | — | — | — | 839.5K | 0.00% | ↗ |
| 52 | 2017 | Susan K. Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | 839.5K | — | — | 839.5K | 100.00% | ↗ |
| 53 | 2017 | Michael Phillips Senior Vice President of Research and Development | 336.8K | 24.5K | — | — | — | — | 697.1K | 0.00% | ↗ |
| 54 | 2017 | Kevin Corcoran Senior Vice President of Market Development | 336.8K | 24.5K | — | — | — | — | 697.1K | 0.00% | ↗ |
| 55 | 2017 | Michael Phillips Former Senior Vice President of Research and Development | 336.8K | — | — | 335.8K | 24.5K | — | 697.1K | 48.17% | ↗ |
| 56 | 2017 | Kathy Ordoñez Chief Commercial Officer and member of the Board of Directors | 1.00 | — | — | — | — | — | 693.3K | 0.00% | ↗ |
| 57 | 2017 | Kathy Ordoñez Chief Commercial Officer and member of the Board of Directors | 1.00 | — | — | — | — | — | 693.3K | 0.00% | ↗ |
| 58 | 2016 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 1.00 | — | — | — | — | — | 1.99M | 0.00% | ↗ |
| 59 | 2016 | Susan Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | — | — | — | 1.24M | 0.00% | ↗ |
| 60 | 2016 | Susan K. Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | — | — | — | 1.24M | 0.00% | ↗ |
| 61 | 2016 | Michael Phillips Senior Vice President of Research and Development | 327.0K | 66.2K | — | — | — | — | 954.5K | 0.00% | ↗ |
| 62 | 2016 | Kevin Corcoran Senior Vice President of Market Development | 327.0K | 66.2K | — | — | — | — | 954.5K | 0.00% | ↗ |
| 63 | 2016 | Kathy Ordoñez Chief Commercial Officer and member of the Board of Directors | — | — | — | — | — | — | — | — | ↗ |
| 64 | 2015 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 1.00 | — | — | — | — | — | 1.45M | 0.00% | ↗ |
| 65 | 2015 | Susan Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | — | — | — | 903.2K | 0.00% | ↗ |
| 66 | 2015 | Michael Phillips Senior Vice President of Research and Development | 317.0K | 107.3K | — | — | — | — | 860.7K | 0.00% | ↗ |
| 67 | 2015 | Kevin Corcoran Senior Vice President of Market Development | 317.0K | 107.3K | — | — | — | — | 860.7K | 0.00% | ↗ |
| 68 | 2014 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 1.00 | — | — | — | — | — | 1.95M | 0.00% | ↗ |
| 69 | 2014 | Susan Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | — | — | — | 1.17M | 0.00% | ↗ |
| 70 | 2014 | Michael Phillips Senior Vice President of Research and Development | 307.5K | 91.5K | — | — | — | — | 846.5K | 0.00% | ↗ |
| 71 | 2014 | Kevin Corcoran Senior Vice President of Market Development | 307.5K | 91.5K | — | — | — | — | 846.5K | 0.00% | ↗ |
| 72 | 2014 | Michael Phillips Senior Vice President Research and Development | 307.5K | 91.5K | — | — | — | — | 846.5K | 0.00% | ↗ |
| 73 | 2013 | Kevin Corcoran Senior Vice President of Market Development | 300.0K | 61.5K | — | 129.0K | — | — | 860.7K | 14.99% | ↗ |
| 74 | 2013 | Susan Barnes Executive Vice President and Chief Financial Officer | 1.00 | — | — | 436.5K | — | — | 860.7K | 50.71% | ↗ |
| 75 | 2013 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 1.00 | — | — | — | — | — | 745.4K | 0.00% | ↗ |
| 76 | 2013 | Michael Phillips Senior Vice President Research and Development | 300.0K | 61.5K | — | — | — | — | 490.5K | 0.00% | ↗ |
| 77 | 2013 | Michael Phillips Senior Vice President of Research and Development | 300.0K | 61.5K | — | 129.0K | — | — | 361.5K | 35.68% | ↗ |
| 78 | 2013 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 1.00 | — | — | 745.4K | — | — | 1.00 | 74,542,100.00% | ↗ |
| 79 | 2012 | Michael Hunkapiller, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 394.1K | — | — | — | — | — | 2.18M | 0.00% | ↗ |
| 80 | 2012 | Michael Hunkapiller, PhD | 394.1K | — | — | 1.78M | — | — | 2.18M | 81.90% | ↗ |
| 81 | 2012 | Kevin Corcoran Senior Vice President of Market Development | 300.0K | 100.2K | — | — | — | — | 1.11M | 0.00% | ↗ |
| 82 | 2012 | Susan Barnes Executive Vice President and Chief Financial Officer | 320.0K | — | — | — | — | — | 1.03M | 0.00% | ↗ |
| 83 | 2012 | Michael Phillips Senior Vice President Research and Development | 300.0K | 100.2K | — | — | — | — | 825.8K | 0.00% | ↗ |
| 84 | 2012 | Michael Glynn Former Chief Commercial Officer | 230.3K | — | — | 283.7K | — | 62.5K | 576.5K | 49.21% | ↗ |
| 85 | 2012 | Hugh C. Martin Former President, Chief Executive Officer and Chairman of the Board of Directors | 4.6K | — | — | — | — | 390.0K | 304.6K | 0.00% | ↗ |
| 86 | 2011 | Kevin Corcoran Senior Vice President of Market Development | 299.4K | 34.5K | — | — | — | — | 1.55M | 0.00% | ↗ |
| 87 | 2011 | Michael Glynn Chief Commercial Officer | 126.4K | 100.0K | — | 1.00M | — | — | 1.23M | 81.55% | ↗ |
| 88 | 2011 | Michael Glynn Former Chief Commercial Officer | 126.4K | 100.0K | — | 1.00M | — | — | 1.23M | 81.55% | ↗ |
| 89 | 2011 | Stephen Turner, Ph.D Chief Technology Officer | 300.0K | 41.3K | — | 125.5K | — | — | 466.8K | 26.89% | ↗ |
| 90 | 2011 | Susan Barnes Executive Vice President and Chief Financial Officer | 320.0K | 78.3K | — | — | — | — | 398.3K | 0.00% | ↗ |
| 91 | 2011 | Michael Phillips Senior Vice President Research and Development | 300.0K | 54.0K | — | — | — | — | 391.7K | 0.00% | ↗ |
| 92 | 2011 | Hugh C. Martin Former President, Chief Executive Officer and Chairman of the Board of Directors | 300.0K | — | — | — | — | — | 300.0K | 0.00% | ↗ |
| 93 | 2010 | Hugh C. Martin President, Chief Executive Officer and Chairman of the Board of Directors | 300.0K | 58.3K | — | 3.65M | — | — | 4.01M | 91.07% | ↗ |
| 94 | 2010 | Hugh C. Martin Former President, Chief Executive Officer and Chairman of the Board of Directors | 300.0K | 58.3K | — | 3.65M | — | — | 4.01M | 91.07% | ↗ |
| 95 | 2010 | Susan Barnes Executive Vice President and Chief Financial Officer | 245.4K | — | — | 2.44M | — | — | 2.69M | 90.87% | ↗ |
| 96 | 2010 | Susan Barnes Executive Vice President and Chief Financial Officer | 245.4K | — | — | 2.44M | — | — | 2.69M | 90.87% | ↗ |
| 97 | 2010 | Michael Phillips Senior Vice President Research and Development | 255.4K | 20.0K | — | 384.0K | — | — | 659.4K | 58.23% | ↗ |
| 98 | 2010 | Stephen Turner, PhD Chief Technology Officer | 275.0K | — | — | 233.9K | — | — | 508.9K | 45.97% | ↗ |
| 99 | 2010 | Stephen Turner, Ph.D Chief Technology Officer | 275.0K | — | — | 233.9K | — | — | 508.9K | 45.97% | ↗ |
| 100 | 2010 | Michael Glynn Chief Commercial Officer | — | — | — | — | — | — | — | — | ↗ |
| 101 | 2010 | Kevin Corcoran Senior Vice President of Market Development | — | — | — | — | — | — | — | — | ↗ |
| 102 | 2009 | Hugh C. Martin President, Chief Executive Officer and Chairman of the Board of Directors | 300.0K | 25.0K | — | 979.0K | — | — | 1.30M | 75.08% | ↗ |
| 103 | 2009 | Stephen Turner, PhD Chief Technology Officer | 275.0K | — | — | — | — | — | 275.0K | 0.00% | ↗ |
| 104 | 2009 | Michael Phillips Senior Vice President Research and Development | 220.0K | 40.0K | — | — | — | — | 260.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Christian O. Henry | President, Chief Executive Officer & Director | 1M | male |
| Mark Van Oene | Chief Operating Officer | 977.2K | male |
| James R. Gibson | CFO & Principal Accounting Officer | 700.5K | male |
| Stephen Turner | Co-Founder | 341.3K | — |
| David Ruggiero | Global Head of Sales & Service | — | male |
| Michele Farmer | Vice President & Chief Accounting Officer | — | female |
| Natalie Welch | Chief People Officer | — | female |
| Brett Atkins | General Counsel & Corporate Secretary | — | — |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PACB
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
